Repligen (RGEN) Will Delay 10-K Sumission; Notes Recent Move to LAF
Get Alerts RGEN Hot Sheet
Revenue Growth %: -17.9%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
CPSS, HARL, MCET, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) filed with the U.S. SEC to delay its 10-K submission. The company offered the following commentary:
Repligen Corporation (the “Company”) intends to file its Form 10-K with the Securities and Exchange Commission as soon as practicable, but no later than March 17, 2015. The Company moved to a Large Accelerator Filer (LAF) for the first time in 2015 and is unable to meet the LAF due date of March 2, 2015 without unreasonable effort and expense, due primarily to the ongoing integration of the business of Refine Technology, LLC, which it acquired in June 2014, into its facilities and financial systems. The Company requires the additional time to finalize its financial statements for fiscal year 2014.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Media & Technology (DJT) Declines 17% on Concerns Stockholders May Sell Shares
- After-hours movers: United Airlines, J.B. Hunt, and more
- Cullinan Therapeutics (CGEM) Announces $280M Placement at $19/sh
Create E-mail Alert Related Categories
Corporate News, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!